Renaissance Technologies decreased its position in Agenus shares, and Agenus filed with the Securities and Exchange Commission.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Renaissance Technologies decreased its position in Agenus shares, and Agenus filed with the Securities and Exchange Commission.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Agenus
biotechnology company
Nothing else this week.
-
Renaissance Technologies
American hedge fund firm
Related events
- Renaissance Technologies filed a disclosure with the SEC on August 18, 2026.
- GreenTree Hospitality Group Ltd. filed reports with the SEC, and Renaissance Technologies adjusted its holdings in the company.
- Renaissance Technologies disclosed a sale of DOCS stock via an SEC legal filing.
- Renaissance Technologies acquired shares listed on Nasdaq on August 16, 2026.
- Renaissance Technologies increased its stake in Enlivex Therapeutics, which is listed on the NASDAQ stock exchange.